Aptose Average Payables from 2010 to 2024
| APTO Stock | USD 0.19 0.01 5.56% |
Average Payables | First Reported 2010-12-31 | Previous Quarter 339.3 K | Current Value 322.3 K | Quarterly Volatility 227 K |
Check Aptose Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aptose Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 83.6 K, Interest Expense of 929.8 K or Selling General Administrative of 16.4 M, as well as many indicators such as Price To Sales Ratio of 12.36, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Aptose financial statements analysis is a perfect complement when working with Aptose Biosciences Valuation or Volatility modules.
Aptose | Average Payables |
Latest Aptose Biosciences' Average Payables Growth Pattern
Below is the plot of the Average Payables of Aptose Biosciences over the last few years. It is the average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers. Aptose Biosciences' Average Payables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aptose Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Average Payables | 10 Years Trend |
|
Average Payables |
| Timeline |
Aptose Average Payables Regression Statistics
| Arithmetic Mean | 393,158 | |
| Geometric Mean | 357,414 | |
| Coefficient Of Variation | 57.72 | |
| Mean Deviation | 135,011 | |
| Median | 298,610 | |
| Standard Deviation | 226,950 | |
| Sample Variance | 51.5B | |
| Range | 966.3K | |
| R-Value | (0.60) | |
| Mean Square Error | 35.4B | |
| R-Squared | 0.36 | |
| Significance | 0.02 | |
| Slope | (30,513) | |
| Total Sum of Squares | 721.1B |
Aptose Average Payables History
About Aptose Biosciences Financial Statements
Aptose Biosciences investors utilize fundamental indicators, such as Average Payables, to predict how Aptose Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Average Payables | 339.3 K | 322.3 K |
Pair Trading with Aptose Biosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aptose Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptose Biosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Aptose Stock
| 0.88 | VALN | Valneva SE ADR | PairCorr |
| 0.86 | ERNA | Eterna Therapeutics | PairCorr |
| 0.7 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
Moving against Aptose Stock
| 0.9 | DYAI | Dyadic International | PairCorr |
| 0.82 | ESPR | Esperion Therapeutics | PairCorr |
| 0.51 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
| 0.5 | DNA | Ginkgo Bioworks Holdings | PairCorr |
The ability to find closely correlated positions to Aptose Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aptose Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aptose Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aptose Biosciences to buy it.
The correlation of Aptose Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aptose Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aptose Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aptose Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Aptose Biosciences Correlation against competitors. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptose Biosciences. If investors know Aptose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptose Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.92) | Return On Assets (1.36) | Return On Equity (6.94) |
The market value of Aptose Biosciences is measured differently than its book value, which is the value of Aptose that is recorded on the company's balance sheet. Investors also form their own opinion of Aptose Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Aptose Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptose Biosciences' market value can be influenced by many factors that don't directly affect Aptose Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptose Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptose Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptose Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.